← Eichor
Condition: Mog Igg Associated Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mog Igg Associated Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Azathioprine in MOGAD
Phase 3 · 17 location(s) · Hospices Civils de Lyon · NCT05349006Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Media
Phase 1 · 1 location(s) · Tongji Hospital · NCT07526493Evaluation of Two Cell-based Assays for Diagnosing MOG-IgG Associated Disorders
Phase N/A · 1 location(s) · Huashan Hospital · NCT06617962
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.